Technical Analysis for GUTS - Fractyl Health, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | N/A | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | 3.71% | |
| Oversold Stochastic | Weakness | 3.71% | |
| New 52 Week Closing Low | Bearish | 7.71% | |
| Lower Bollinger Band Walk | Weakness | 7.71% | |
| Below Lower BB | Weakness | 7.71% | |
| Lower Bollinger Band Touch | Weakness | 7.71% | |
| Oversold Stochastic | Weakness | 7.71% | |
| Slingshot Bearish | Bearish Swing Setup | 3.20% | |
| NR7 | Range Contraction | 3.20% | |
| Narrow Range Bar | Range Contraction | 3.20% |
| Alert | Time |
|---|---|
| 10 DMA Resistance | about 12 hours ago |
| Rose Above 10 DMA | about 13 hours ago |
| Up 5% | about 13 hours ago |
| Rose Above Previous Day's High | about 13 hours ago |
| 2x Volume Pace | about 13 hours ago |
Get a Trading Assistant
- Earnings date: 05/13/2024
Fractyl Health, Inc. Description
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It also develops Rejuva, a novel virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is based in Lexington, Massachusetts.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Diabetes Gene Therapy Obesity
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 14.5 |
| 52 Week Low | 3.765 |
| Average Volume | 181,754 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 5.45 |
| 20-Day Moving Average | 4.34 |
| 10-Day Moving Average | 4.24 |
| Average True Range | 0.35 |
| RSI (14) | 40.83 |
| ADX | 32.24 |
| +DI | 16.77 |
| -DI | 26.91 |
| Chandelier Exit (Long, 3 ATRs) | 3.87 |
| Chandelier Exit (Short, 3 ATRs) | 4.82 |
| Upper Bollinger Bands | 4.84 |
| Lower Bollinger Band | 3.84 |
| Percent B (%b) | 0.35 |
| BandWidth | 23.15 |
| MACD Line | -0.35 |
| MACD Signal Line | -0.38 |
| MACD Histogram | 0.032 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 4.54 | ||||
| Resistance 3 (R3) | 4.53 | 4.40 | 4.48 | ||
| Resistance 2 (R2) | 4.40 | 4.31 | 4.40 | 4.46 | |
| Resistance 1 (R1) | 4.29 | 4.25 | 4.35 | 4.31 | 4.44 |
| Pivot Point | 4.16 | 4.16 | 4.19 | 4.17 | 4.16 |
| Support 1 (S1) | 4.06 | 4.07 | 4.11 | 4.07 | 3.94 |
| Support 2 (S2) | 3.93 | 4.02 | 3.93 | 3.92 | |
| Support 3 (S3) | 3.82 | 3.93 | 3.90 | ||
| Support 4 (S4) | 3.84 |
